Table 1 Participant demographics and global brain measures for 22q11.2DS compared to controls.

From: Brain morphometry in 22q11.2 deletion syndrome: an exploration of differences in cortical thickness, surface area, and their contribution to cortical volume

 

22q11.2DS

Control

Significance

(n = 62 [30♂, 32♀] )

(n = 57 [27♂, 30♀])

t(117)

p

Age, years

16 ± 7

(6–31)

15 ± 6

(6–27)

0.71

0.48

Full-scale IQ

82 ± 13

(60–116)

114 ± 16

(76–148)

− 11.84

< 0.001

Total Grey Vol (L)

0.59 ± 0.23

(0.41–0.89)

0.64 ± 0.24

(0.41–0.89)

− 1.29

0.201

Average CT (mm)

2.72 ± 0.14

(2.59–3.06)

2.73 ± 0.12

(2.46–2.99)

− 0.64

0.522

Total SA (m2)

0.20 ± 0.20

(0.13–0.25)

0.23 ± 0.20

(0.19–0.27)

− 5.95

< 0.001

Psychotropic medication (none/antipsych/antidep/stimul)

(43/5/10/4)

(49/0/6/2)

  
  1. Data expressed as mean ± standard deviation (range). Medication: none: no medication; antipsych: antipsychotic medication; antidep: antidepressant medication; stimul: psychostimulant medication.
Back to article page